Insider · CIK 0001240801
FORSYTH DOUGLAS
Reports to the SEC for 13 companies · LA JOLLA, CA
Transactions
28
Companies
13
Filings
12
CIK
0001240801
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-08 | INBXInhibrx Biosciences, Inc.P Purchase | +$287K |
| 2026-06-03 | INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award | — |
| 2026-06-03 | INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award | — |
| 2025-05-28 | INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award | — |
| 2024-08-23 | INBXInhibrx Biosciences, Inc.P Purchase | +$842K |
| 2024-08-22 | INBXInhibrx Biosciences, Inc.P Purchase | +$196K |
| 2024-05-30 | Inhibrx, Inc.D Disposition to Issuer | −$17.9M |
| 2024-05-30 | Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-05-30 | INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award | — |
| 2024-05-30 | Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-05-30 | Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-05-30 | Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-05-29 | INBXInhibrx Biosciences, Inc.A Award | — |
| 2023-05-25 | Inhibrx, Inc.Stock Option (right to buy)A Award | — |
| 2022-05-25 | Inhibrx, Inc.Stock Option (right to buy)A Award | — |
| 2021-06-07 | Inhibrx, Inc.Stock Option (right to buy)A Award | — |
| 2020-08-21 | Inhibrx, Inc.C Conversion | — |
| 2020-08-21 | Inhibrx, Inc.Series Mezzanine 2 Preferred StockC Conversion | — |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$247K |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$2,469 |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$2,467.2 |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$19.7K |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$44.2K |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$17.5K |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$46.8K |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$14.8K |
| 2020-08-11 | NIEVirtus Equity & Convertible Income FundS Sale | −$98.5K |
| 2007-08-15 | NCVVirtus Convertible & Income FundP Purchase | +$51.4K |
Recent filings
- 4/AFORSYTH DOUGLAS0001240801-26-000006SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0001240801-26-000004SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0001240801-26-000002SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0002007919-25-000066SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0002007919-24-000040SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0000950142-24-001491SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0000950142-24-001498SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0001739614-23-000056SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0001739614-22-000067SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0001739614-21-000072SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0001628280-20-012983SEC(opens sec.gov)
- 4FORSYTH DOUGLAS0001209191-20-046509SEC(opens sec.gov)
Companies
- AllianzGI Global Equity & Convertible Income FundAffiliated Person
- AllianzGI International & Premium Strategy FundAffiliated Person
- China Fund, Inc.Affiliated Person
- Inhibrx Biosciences, Inc.DirectorINBX
- Inhibrx, Inc.Director
- KOREA FUND INCAffiliated PersonKF
- TAIWAN FUND INCAffiliated PersonTWN
- Virtus Convertible & Income 2024 Target Term FundPortfolio Manager
- Virtus Convertible & Income FundAffiliated PersonNCV
- Virtus Convertible & Income Fund IIVice President/Portfolio Mgr.NCZ
- Virtus Diversified Income & Convertible FundAffiliated PersonACV
- Virtus Dividend, Interest & Premium Strategy FundPortfolio ManagerNFJ
- Virtus Equity & Convertible Income FundAffiliated PersonNIE
Address
C/O INHIBRX BIOSCIENCES, INC. 11025 NORTH TORREY PINES ROAD, SUITE 140
LA JOLLA, CA, 92037